The OCD and Related Disorders Program at the Massachusetts General Hospital/Harvard Medical School is located in Boston, Massachusetts. Founded in 1980 by Michael Jenike, M.D., our program is one of the oldest and largest psychiatric specialty clinics in the world. Since 2007, the program has been under the leadership of Sabine Wilhelm, Ph.D., Chief of Psychology at Mass General, Professor at Harvard Medical School and an internationally known researcher in OCD and related disorders. Our distinguished team includes psychiatrists, psychologists, post-doctoral psychology fellows, pre-doctoral psychology interns, program managers, clinical research coordinators, biostatisticians, and intake coordinators.
Our multidisciplinary program integrates genetics, neuroscience, neurophysiology, technology and clinical research to understand, assess, and treat OCD and related disorders. Our program is set up to deliver excellent evidence-based treatment and conduct cutting-edge research on:
- the causes of OCD and related disorders
- how effectively CBT can be delivered in the “real-world”
- how and for whom treatments for OCD and related disorders work
- whether novel treatments might be used to treat OCD and related disorders.
We provide state-of-the-art outpatient care, including cognitive-behavioral therapy (i.e., exposure and response prevention and cognitive therapy), medication, transcranial magnetic stimulation, deep brain stimulation, and neurosurgery. We also provide one-time consultations, evaluations, and follow-up care. Treatment delivered in the context of research studies is provided at no cost to the patients.
Aligned with our training/education mission, we are dedicated to enhancing access to care through clinician training and new, technology-based treatments that offer a low-barrier, high-quality treatment option.
Our research portfolio ranges from novel treatment interventions, state-of-the art technology-based assessment and treatment, neural correlates of behavior therapy, to genetic and cognitive processes underlying OCD and related disorders.
Our mission is to improve the lives of people suffering from OCD and related disorders through excellence in patient care, research, and training/education. Our ultimate goal is remission and recovery from OCD and related disorders. In line with our mission, our clinical research program provides comprehensive evaluation and evidence-based treatment for patients, offers guidance and support for their loved ones, and conducts cutting-edge research to advance our knowledge of the causes, consequences and treatments of these disorders. We are dedicated to educating mental health professionals and trainees, families, and the general public to improve access and quality of care for those who suffer.